Morgan Molloy
Chief Corporate Development Officer at Atalanta Therapeutics
📍 Greater Boston, United States
Professional overview including current role context, leadership scope, domain focus, and career trajectory to help you understand background relevance before outreach.
Key behavioral and communication insights including interaction style, decision-making tendencies, and motivation drivers to tailor messaging and personalize conversations.
Business priorities, areas of interest, and practical outreach recommendations that can improve conversion quality for this professional.
Experience
15 Years
Current Role
Chief Corporate Development Officer
Location
Greater Boston, United States
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Morgan cares about
Strategic Priorities
Topic insights and context to help personalize outreach and discovery conversations.
Career
Work history
9-2021 - 11-2025
Chief Corporate Development Officer
Atalanta Therapeutics
1-2020 - 4-2021
Chief Corporate Development Officer
Akouos
9-2017 - 11-2019
Chief Commercial Officer
Enzyvant
1-2015 - 8-2017
Head of US Commercial
Spark Therapeutics, Inc.
5-2012 - 1-2015
Vice President, Global Disease Lead, Fabry Disease
Genzyme
In the press
Media appearances
Media appearances and press coverage highlighting public visibility and thought leadership.
Login to view
Education
Morgan has no verified education history
Social presence
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.